Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma
{{output}}
Purpose of review: Renal cell carcinoma (RCC) was recognized as an immunologically sensitive cancer over 30 years ago. The first therapies to affect the course of RCC were cytokines (interferon alfa-2B and interleukin-2). Subsequ... ...
